Sema4 Holdings Corp. (NASDAQ: SMFR) stock fell -1.56% on Friday to $0.91 against a previous-day closing price of $0.92. With 1.02 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.87 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.9202 whereas the lowest price it dropped to was $0.8600. The 52-week range on SMFR shows that it touched its highest point at $9.18 and its lowest point at $0.91 during that stretch. It currently has a 1-year price target of $3.25.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SMFR was down-trending over the past week, with a drop of -9.04%, but this was down by -18.79% over a month. Three-month performance dropped to -46.81% while six-month performance fell -66.68%. The stock lost -88.44% in the past year, while it has lost -79.61% so far this year. A look at the trailing 12-month EPS for SMFR yields -0.60 with Next year EPS estimates of -0.65. For the next quarter, that number is -0.21. This implies an EPS growth rate of 1.90% for this year and 31.90% for next year.
Float and Shares Shorts:
At present, 337.75 million SMFR shares are outstanding with a float of 181.40 million shares on hand for trading. On Jul 14, 2022, short shares totaled 13.63 million, which was 3.61% higher than short shares on Jun 14, 2022. In addition to Mr. Jason Ryan as the firm’s Exec. Chair of the Board, Dr. Eric E. Schadt Ph.D. serves as its Founder, Pres, Director and Chief R&D Officer.
Through their ownership of 36.61% of SMFR’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.69% of SMFR, in contrast to 4.59% held by mutual funds. Shares owned by individuals account for 28.19%. As the largest shareholder in SMFR with 4.95% of the stake, Deerfield Management Co. LP holds 18,848,488 shares worth 18,848,488. A second-largest stockholder of SMFR, Casdin Capital LLC, holds 16,437,500 shares, controlling over 4.32% of the firm’s shares. Corvex Management LP is the third largest shareholder in SMFR, holding 15,937,500 shares or 4.19% stake. With a 1.04% stake in SMFR, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 3,961,376 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 1.03% of SMFR stock, is the second-largest Mutual Fund holder. It holds 3,937,054 shares valued at 4.02 million. iShares Russell 2000 ETF holds 0.85% of the stake in SMFR, owning 3,217,632 shares worth 3.28 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SMFR since 4 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SMFR analysts setting a high price target of $5.00 and a low target of $2.00, the average target price over the next 12 months is $3.25. Based on these targets, SMFR could surge 449.45% to reach the target high and rise by 119.78% to reach the target low. Reaching the average price target will result in a growth of 257.14% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SMFR will report FY 2022 earnings on 03/13/2023. Analysts have provided yearly estimates in a range of -$0.76 being high and -$1.12 being low. For SMFR, this leads to a yearly average estimate of -$0.93. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Sema4 Holdings Corp. surprised analysts by -$0.01 when it reported -$0.22 EPS against a consensus estimate of -$0.20. The surprise factor in the prior quarter was $0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.13 and the low estimate is -$0.30. The average estimate for the next quarter is thus -$0.21.
Summary of Insider Activity:
Insiders traded SMFR stock several times over the past three months with 5 Buys and 5 Sells. In these transactions, 92,897 shares were bought while 30,603 shares were sold. The number of buy transactions has increased to 59 while that of sell transactions has risen to 38 over the past year. The total number of shares bought during that period was 26,176,311 while 318,288 shares were sold.